Magnetically induced controlled release from glucose-modified liposomes loaded with Fe3O4 nanoparticles
Source abstract
Abstract
Small glucose-modified liposomes (GMLs) were loaded with magnetic Fe3O4 nanoparticles (MNPs) and fluorescein using a standard thin layer preparation procedure and a varying lipid/MNPs ratio. The liposomes were characterized with TEM and DLS measurements, and MNPs encapsulation rate was determined using ICP-OES. Prepared liposomes were stored at 5 °C for 30 days and subsequently exposed to an external magnetic field (20 mT) with varying exposure times (2‒20 min), at room temperature. The release of fluorescein from GMLs induced by the magnetic field exposures was quantified, showing a high release rate (25‒85%) depending on the concentration of MNPs in GMLs. EPR measurements were conducted during the liposomes storage period in order to provide semi-quantitative information of possible MNPs oxidation from Fe3O4 to Fe2O3 inside the liposomes, impacting MNPs magnetic properties. In contrast to the MNPs water dispersion, no significant change in the EPR signal of MNPs encapsulated inside GMLs was detected over the course of 30 days. The data presented in this study indicate that GMLs loaded with MNPs maintain a high stability for prolonged periods of time and that this delivery system may be used for magnetically assisted controlled drug release.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Laviano A, Rossi Fanelli F (2012) Toxicity in chemotherapy — when less is more N Engl J Med. 366: 2319–2320. https://doi.org/10.1056/nejmcibr1202395.10.1056/nejmcibr1202395 ↗
2. Iwamoto T (2013) Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biol Pharm Bull 36:715–718. https://doi.org/10.1248/bpb.b12-0110210.1248/bpb.b12-01102 ↗
3. Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalt Trans 47:6645–6653. https://doi.org/10.1039/c8dt00838h10.1039/c8dt00838h ↗
4. Sawyers C (2004) Targeted cancer therapy. Nature 432:294–297. https://doi.org/10.1038/nature0309510.1038/nature03095 ↗
5. Rodzinski A, Guduru R, Liang P, Hadjikhani A, Stewart T, Stimphil E, Runowicz C, Cote R, Altman N, Datar R, Khizroev S (2016) Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. Sci Rep 6:1–14. https://doi.org/10.1038/srep2086710.1038/srep20867 ↗
6. Liu JF, Jang B, Issadore D, Tsourkas A (2019) Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting, Wiley Interdiscip. Rev. Nanomedicine. NanoBiotechnology 11:1–18. https://doi.org/10.1002/wnan.157110.1002/wnan.1571 ↗
7. Bennett DE, Lamparski H, O’brien DF (1994) Photosensitive liposomes. J Liposome Res. 4: 331–348. https://doi.org/10.3109/0898210940903704810.3109/08982109409037048 ↗
8. Ginsberg R, Pilkiewicz F, Ginsberg R, Brenner DE, Tung Y, Petrelli N (1993) Initial Clinical (phase i) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res 53:2796–2802
9. Cvjetinović Đ, Prijović Ž, Janković D, Radović M, Mirković M, Milanović Z, Mojović M, Škalamera Đ, Vranješ-Đurić S (2021) Bioevaluation of glucose-modified liposomes as a potential drug delivery system for cancer treatment using 177-Lu radiotracking. J Control Release 332:301–311. https://doi.org/10.1016/j.jconrel.2021.03.00610.1016/j.jconrel.2021.03.006 ↗
10. Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:1–33. https://doi.org/10.3390/pharmaceutics902001210.3390/pharmaceutics9020012 ↗
11. Zhang Y, Xuan S, Owoseni O, Omarova M, Li X, Saito ME, He J, McPherson GL, Raghavan SR, Zhang D, John VT (2017) Amphiphilic polypeptoids serve as the connective glue to transform liposomes into multilamellar structures with closely spaced bilayers. Langmuir 33:2780–2789. https://doi.org/10.1021/acs.langmuir.6b0419010.1021/acs.langmuir.6b04190 ↗
12. Blume G, Cevc G (1990) Liposomes for the sustained drug release in vivo. BBA - Biomembr 1029:91–97. https://doi.org/10.1016/0005-2736(90)90440-Y10.1016/0005-2736(90)90440-Y ↗
13. Bangham AD (1993) Liposomes: the Babraham connection. Chem Phys Lipids 64:275–285. https://doi.org/10.1016/0009-3084(93)90071-A10.1016/0009-3084(93)90071-A ↗
14. Madni MA, Sarfraz M, Rehman M, Ahmad M, Akhtar N, Ahmad S, Tahir N, Ijaz S, Al-Kassas R, Löbenberg R (2014) Liposomal drug delivery: a versatile platform for challenging clinical applications. J Pharm Pharm Sci 17: 401–426. https://doi.org/10.18433/j3cp5510.18433/j3cp55 ↗
15. Mozafari MR, Reed CJ, Rostron C (2007) Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents. Pharmazie 62:205–209. https://doi.org/10.1691/ph.2007.3.604510.1691/ph.2007.3.6045 ↗
16. Allen TM, Martin FJ (2004) Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 31:5–15. https://doi.org/10.1053/j.seminoncol.2004.08.00110.1053/j.seminoncol.2004.08.001 ↗
17. Gabizon A, Shmeeda H, Barenholz Y (2003) Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42:419–436. https://doi.org/10.2165/00003088-200342050-0000210.2165/00003088-200342050-00002 ↗
18. Balazsovits JAE, Mayer LD, Bally MB, Cullis PR, McDonell M, Ginsberg RS, Falk RE (1989) Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol 23:81–86. https://doi.org/10.1007/BF0027352210.1007/BF00273522 ↗
19. He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–3666. https://doi.org/10.1016/j.biomaterials.2010.01.06510.1016/j.biomaterials.2010.01.065 ↗
20. Zumbuehl O, Weder HG (1981) Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles. BBA - Biomembr 640:252–262. https://doi.org/10.1016/0005-2736(81)90550-210.1016/0005-2736(81)90550-2 ↗
21. Ren H, He Y, Liang J, Cheng Z, Zhang M, Zhu Y, Hong C, Qin J, Xu X, Wang J (2019) Role of liposome size, surface charge, and pegylation on rheumatoid arthritis targeting therapy. ACS Appl Mater Interfaces 11:20304–20315. https://doi.org/10.1021/acsami.8b2269310.1021/acsami.8b22693 ↗
22. Chono S, Tanino T, Seki T, Morimoto K (2007) Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol 59:75–80. https://doi.org/10.1211/jpp.59.1.001010.1211/jpp.59.1.0010 ↗
23. Litzinger DC, Buiting AMJ, van Rooijen N, Huang L (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. BBA - Biomembr 1190:99–107. https://doi.org/10.1016/0005-2736(94)90038-810.1016/0005-2736(94)90038-8 ↗
24. Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–478. https://doi.org/10.1016/S0163-7827(03)00033-X10.1016/S0163-7827(03)00033-X ↗
25. Li XM, Ding LY, Xu Y, Wang Y, Ping QN (2009) Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 373:116–123. https://doi.org/10.1016/j.ijpharm.2009.01.02310.1016/j.ijpharm.2009.01.023 ↗
26. Ancey PB, Contat C, Meylan E (2018) Glucose transporters in cancer – from tumor cells to the tumor microenvironment. FEBS J 285:2926–2943. https://doi.org/10.1111/febs.1457710.1111/febs.14577 ↗
27. Szablewski L (1835) Expression of glucose transporters in cancers. Biochim Biophys Acta - Rev Cancer 2013:164–169. https://doi.org/10.1016/j.bbcan.2012.12.00410.1016/j.bbcan.2012.12.004 ↗
28. Adekola K, Rosen ST, Shanmugam M (2012) Glucose transporters in cancer metabolism. Curr Opin Oncol 24:650–654. https://doi.org/10.1097/CCO.0b013e328356da7210.1097/CCO.0b013e328356da72 ↗
29. Maisey MN (2002) Overview of clinical PET. Br J Radiol 75:S1–S5. https://doi.org/10.1259/bjr.75.suppl_9.75000110.1259/bjr.75.suppl_9.750001 ↗
30. Chen Y, Bose A, Bothun GD (2010) Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. ACS Nano 4:3215–3221. https://doi.org/10.1021/nn100274v10.1021/nn100274v ↗
31. Biltonen RL, Lichtenberg D (1993) The use of differential scanning calorimetry as a tool to characterize liposome preparations. Chem Phys Lipids 64:129–142. https://doi.org/10.1016/0009-3084(93)90062-810.1016/0009-3084(93)90062-8 ↗
32. Qin Y, Fan W, Chen H, Yao N, Tang W, Tang J, Yuan W, Kuai R, Zhang Z, Wu Y, He Q (2010) In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes. J Drug Target 18:536–549. https://doi.org/10.3109/1061186100358723510.3109/10611861003587235 ↗
33. Perić M, Radović M, Mirković M, Nikolić AS, Iskrenović P, Janković D, Vranješ-Đurić S (2019) The analysis of 2,3-dicarboxypropane-1,1-diphosphonic acid-coated magnetite nanoparticles under an external magnetic field and their radiolabeling for possible theranostic applications. New J Chem 43:5932–5939. https://doi.org/10.1039/c8nj06478d10.1039/c8nj06478d ↗
34. Mady MM, Fathy MM, Youssef T, Khalil WM (2012) Biophysical characterization of gold nanoparticles-loaded liposomes. Phys Medica 28:288–295. https://doi.org/10.1016/j.ejmp.2011.10.00110.1016/j.ejmp.2011.10.001 ↗
35. Adams S, Bonabi S, Allen A, Roseman G, Ramirez AP, Millhauser G, Zhang JZ (2019) The effect of polymer and gold functionalization on the magnetic properties of magnetite nanoparticles, Biomed. Spectrosc. Imaging 7:115–124. https://doi.org/10.3233/BSI-18018210.3233/BSI-180182 ↗
36. Noginov MM, Noginova N, Amponsah O, Bah R, Rakhimov R, Atsarkin VA (2008) Magnetic resonance in iron oxide nanoparticles: quantum features and effect of size. J Magn Magn Mater 320:2228–2232. https://doi.org/10.1016/j.jmmm.2008.04.15410.1016/j.jmmm.2008.04.154 ↗
37. Can MM, Coşkun M, Firat T (2012) A comparative study of nanosized iron oxide particles; Magnetite (Fe 3O 4), maghemite (γ-Fe 2O 3) and hematite (α-Fe 2O 3), using ferromagnetic resonance. J Alloys Compd 542:241–247. https://doi.org/10.1016/j.jallcom.2012.07.09110.1016/j.jallcom.2012.07.091 ↗
38. Upadhyay RV, Srinivas D, Mehta RV (2000) Magnetic resonance in nanoscopic particles of a ferrofluid. J Magn Magn Mater 214:105–111. https://doi.org/10.1016/S0304-8853(99)00811-210.1016/S0304-8853(99)00811-2 ↗
39. Sastry MD, Nagar YC, Bhushan B, Mishra KP, Balaram V, Singhvi AK (2008) An unusual radiation dose dependent EPR line at geff = 2.54 in feldspars: Possible evidence of Fe3+O2- ↔ Fe 2+O- and exchange coupled Fe3+-Fe 2+-nO-, J Phys Condens Matter. 20. https://doi.org/10.1088/0953-8984/20/02/025224.10.1088/0953-8984/20/02/025224 ↗
40. Anand M, Carrey J, Banerjee V (2016) Spin morphologies and heat dissipation in spherical assemblies of magnetic nanoparticles. Phys Rev B 94:1–12. https://doi.org/10.1103/PhysRevB.94.09442510.1103/PhysRevB.94.094425 ↗
41. Tan RP, Carrey J, Respaud M (2014) Magnetic hyperthermia properties of nanoparticles inside lysosomes using kinetic Monte Carlo simulations: influence of key parameters and dipolar interactions, and evidence for strong spatial variation of heating power. Phys Rev B - Condens Matter Mater Phys. 90: 1–12. https://doi.org/10.1103/PhysRevB.90.214421.10.1103/PhysRevB.90.214421 ↗
42. S. Islam, A. Khan, G.M.S. Rahman, H. Aftab, A comparative study on heat dissipation , morphological and magnetic properties of hyperthermia suitable ... Simple Hydrothermal Synthesis and Morphological Study of Magnetic Nanoparticles, 35 (2016) 1047–1053.10.1007/s12034-012-0414-3 ↗
43. Domenech M, Marrero-Berrios I, Torres-Lugo M, Rinaldi C (2013) Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano 7:5091–5101. https://doi.org/10.1021/nn400704810.1021/nn4007048 ↗
44. Sanchez C, El Hajj Diab D, Connord V, Clerc P, Meunier E, Pipy B, Payré B, Tan RP, Gougeon M, Carrey J, Gigoux V, Fourmy D (2014) Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death. ACS Nano. 8: 1350–1363. https://doi.org/10.1021/nn404954s.10.1021/nn404954s ↗
45. Guo H, Chen W, Sun X, Liu YN, Li J, Wang J (2015) Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field. Carbohydr Polym 118:209–217. https://doi.org/10.1016/j.carbpol.2014.10.07610.1016/j.carbpol.2014.10.076 ↗
46. Anand M (2021) Hysteresis in two dimensional arrays of magnetic nanoparticles. J Magn Magn Mater 540:168461. https://doi.org/10.1016/j.jmmm.2021.16846110.1016/j.jmmm.2021.168461 ↗
47. Anand M (2020) Hysteresis in a linear chain of magnetic nanoparticles. J Appl Phys 128. https://doi.org/10.1063/5.001021710.1063/5.0010217 ↗
48. Mirković M, Radović M, Stanković D, Milanović Z, Janković D, Matović M, Jeremić M, Antić B, Vranješ-Đurić S (2019) 99mTc–bisphosphonate–coated magnetic nanoparticles as potential theranostic nanoagent. Mater Sci Eng C 102:124–133. https://doi.org/10.1016/j.msec.2019.04.03410.1016/j.msec.2019.04.034 ↗
49. Zhang JQ, Zhang ZR, Yang H, Tan QY, Qin SR, Qiu XL (2005) Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm Res 22:573–583. https://doi.org/10.1007/s11095-005-2496-810.1007/s11095-005-2496-8 ↗
50. Ye H, Tong J, Liu J, Lin W, Zhang C, Chen K, Zhao J, Zhu W (2016) Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: a possible mechanism with potential for clinical application. Oncotarget 7: 43762–43778. https://doi.org/10.18632/oncotarget.9671.10.18632/oncotarget.9671 ↗
51. Wang X, Yang R, Yuan C, An Y, Tang Q, Chen D (2018) Preparation of folic acid-targeted temperature-sensitive magnetoliposomes and their antitumor effects in vitro and in vivo, target. Oncol 13:481–494. https://doi.org/10.1007/s11523-018-0577-y10.1007/s11523-018-0577-y ↗